SYNOPSYS INC
For the period ended Apr 30, 2026. Filed May 27, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Apr 30, 2026 · Filed May 27, 2026
SNPS$459.95-1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| April 30,2026 | October 31,2025 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $2,412,472 | $2,888,030 |
| Short-term investments | 71,966 | 72,929 |
| Total cash, cash equivalents and short-term investments | 2,484,438 | 2,960,959 |
| Accounts receivable, net | 1,267,305 | 1,505,427 |
| Inventories | 441,836 | 365,190 |
| Prepaid and other current assets | 1,195,391 | 1,180,526 |
| Current assets held for sale | 48,248 | — |
| Total current assets | 5,437,218 | 6,012,102 |
| Property and equipment, net | 714,744 | 696,693 |
| Operating lease right-of-use assets, net | 697,112 | 702,008 |
| Goodwill | 26,853,807 | 26,899,215 |
| Intangible assets, net | 11,875,418 | 12,679,591 |
| Deferred income taxes | 113,642 | 112,159 |
| Other long-term assets | 1,197,086 | 1,122,693 |
| Total assets | $46,889,027 | $48,224,461 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable and accrued liabilities | $1,185,204 | $1,326,211 |
| Operating lease liabilities | 135,523 | 128,205 |
| Deferred revenue | 2,419,876 | 2,245,961 |
| Short-term debt | 22,117 | 22,117 |
| Current liabilities held for sale | 27,912 | — |
| Total current liabilities | 3,790,632 | 3,722,494 |
| Long-term operating lease liabilities | 670,475 | 680,698 |
| Long-term deferred revenue | 389,419 | 382,557 |
| Long-term debt | 10,013,845 | 13,462,398 |
| Other long-term liabilities | 1,547,591 | 1,649,299 |
| Total liabilities | 16,411,962 | 19,897,446 |
| Stockholders’ equity: | ||
| Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding | — | — |
| Common stock, $0.01 par value: 400,000 shares authorized; 191,444 and 185,994 shares outstanding, respectively | 1,928 | 1,860 |
| Capital in excess of par value | 20,565,562 | 18,640,947 |
| Retained earnings | 10,397,550 | 10,315,487 |
| Treasury stock, at cost: 593 and 1,222 shares, respectively | (242,827) | (398,278) |
| Accumulated other comprehensive loss | (244,082) | (232,414) |
| Total Synopsys stockholders’ equity | 30,478,131 | 28,327,602 |
| Non-controlling interest | (1,066) | (587) |
| Total stockholders’ equity | 30,477,065 | 28,327,015 |
| Total liabilities and stockholders’ equity | $46,889,027 | $48,224,461 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.